| Wentrup A, Oertel WH, Dodel R
Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:245-254.
Abstract | Full Citation | Find Related Articles |
| Bailey JA, Lahiri DK
A novel effect of rivastigmine on presynaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease. [JOURNAL ARTICLE]
J Neurochem 2009 Nov 11.
Abstract | Full Citation | Find Related Articles |
| Leifer BP
Alzheimer's disease: Seeing the signs early. [Journal Article, Research Support, Non-U.S. Gov't]
J Am Acad Nurse Pract 2009 Nov; 21(11):588-95.
Abstract | Full Citation |
| Gauthier S, Scheltens P
Can we do better in developing new drugs for Alzheimer's disease? [Editorial]
Alzheimers Dement 2009 Nov; 5(6):489-91.
Abstract | Full Citation | Find Related Articles |
| Lockhart IA, Mitchell SA, Kelly S
Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence. [JOURNAL ARTICLE]
Dement Geriatr Cogn Disord 2009 Nov 6; 28(5):389-403.
Abstract | Full Citation | Find Related Articles |
| Mumoli N, Carmignani G, Luschi R, et al.
Hepatitis with cholestasis caused by rivastigmine transdermal patch. [Letter]
Am J Gastroenterol 2009 Nov; 104(11):2859-60.
Full Citation |
| Darreh-Shori T, Soininen H
Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimer's Disease: A Review of Recent Clinical Studies. [JOURNAL ARTICLE]
Curr Alzheimer Res 2009 Sep 28.
Abstract | Full Citation |
| Carlos Machado J
Review: rivastigmine reduces rate of cognitive decline and improves performance in mild to moderate Alzheimer's. [Journal Article]
Evid Based Ment Health 2009 Nov; 12(4):113.
Full Citation | Publisher Full Text | Find Related Articles |
| Chiu PY, Dai DE, Hsu HP, et al.
Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. [Journal Article]
Clin Drug Investig 2009; 29(11):729-38.
Abstract | Full Citation | Find Related Articles |
| Parlayan E, Yulug B, Bakar M, et al.
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect. [Letter]
J Neuropsychiatry Clin Neurosci 2009; 21(3):348-50.
Full Citation | Publisher Full Text | Find Related Articles |
  |
